- Report
- October 2023
- 145 Pages
Global
From €2779EUR$3,150USD£2,433GBP
- Report
- October 2023
- 145 Pages
Global
From €2779EUR$3,150USD£2,433GBP
- Report
- August 2024
- 60 Pages
Global
From €1059EUR$1,200USD£927GBP
€1323EUR$1,500USD£1,159GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €2647EUR$3,000USD£2,318GBP
€3308EUR$3,750USD£2,897GBP
- Report
- July 2024
- 231 Pages
Global
From €5611EUR$6,360USD£4,913GBP
€7014EUR$7,950USD£6,142GBP
- Drug Pipelines
- April 2024
- 202 Pages
Global
From €5611EUR$6,360USD£4,913GBP
€7014EUR$7,950USD£6,142GBP
- Report
- February 2024
- 30 Pages
United States
€1588EUR$1,800USD£1,391GBP
€1985EUR$2,250USD£1,738GBP
- Report
- November 2023
- 30 Pages
Global
From €2294EUR$2,600USD£2,009GBP
€2867EUR$3,250USD£2,511GBP
- Report
- May 2023
- 450 Pages
Global
From €3529EUR$4,000USD£3,090GBP
€4411EUR$5,000USD£3,863GBP
- Report
- April 2023
- 180 Pages
Global
From €2117EUR$2,400USD£1,854GBP
€2647EUR$3,000USD£2,318GBP
- Report
- April 2023
- 137 Pages
Global
From €5294EUR$6,000USD£4,635GBP
€6617EUR$7,500USD£5,794GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1941EUR$2,200USD£1,700GBP
€2426EUR$2,750USD£2,124GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1941EUR$2,200USD£1,700GBP
€2426EUR$2,750USD£2,124GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1941EUR$2,200USD£1,700GBP
€2426EUR$2,750USD£2,124GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1941EUR$2,200USD£1,700GBP
€2426EUR$2,750USD£2,124GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1941EUR$2,200USD£1,700GBP
€2426EUR$2,750USD£2,124GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1941EUR$2,200USD£1,700GBP
€2426EUR$2,750USD£2,124GBP
- Report
- February 2022
- 210 Pages
Global
From €5294EUR$6,000USD£4,635GBP
€6617EUR$7,500USD£5,794GBP
- Report
- April 2023
- 115 Pages
Global
From €4191EUR$4,750USD£3,670GBP
- Report
- June 2022
- 120 Pages
Global
From €4191EUR$4,750USD£3,670GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more